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3D Molecular modelingAbstract Thepresent paper reports the synthesis and characterization of somenew sulfa drugbased Schiff
base oxovanadium(IV) complexes of composition, [VO(sal-sdz)2(H2O)]ÆH2O, [VO(sal-sgn)2(H2O)]ÆH2O,




diaminodiphenylsulfone, respectively. Complexes, (1)–(4) were prepared by the reaction of VOSO4Æ5H2O
with the Schiff bases in 1:2 metal-ligand ratio while complex (5) in 2:2 metal-ligand ratio in DMF-ethanol
medium.The compounds so obtainedwere characterized by different physico-chemical studies, such as, ele-
mental analysis,molar conductance andmagneticmeasurements, infrared,ESR, thermogravimetric studies,
mass and electronic spectral studies. The overall IR studies conclude that the ligand in complex (1)–(4)
behaveasmonobasicbidentateONdonor,while the ligand in the complex (5)behavesasdibasic tetradentate
O2N2 donor. The 3D-molecular modeling and analysis for bond lengths and bond angles have also been
Table 1 Characterization data of t






Oxovanadium(IV) complexes of bioinorganic and medicinal relevance: Synthesis, characterization S1085carried out for two representative compounds, [VO(sal-snm)2(H2O)]ÆH2O (3) and [VO(dadps)(H2O)]2Æ2H2O
(5) to substantiate the proposed structures. Based on these studies suitable octahedral structures have been
proposed for these complexes.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Sulfa drugs are an important class of therapeutic (Pharmaco-
poeia of India, 1983) compounds. In combination with certain
other drugs, they are used for the treatment of various bacte-
rial infections. Study of the coordination behavior of sulfa
drugs is of considerable interest because the coordination of
metal ion is reported to enhance the biological activities of or-
ganic compounds.
The sulfa drugs, derivatives of a compound p-aminoben-
zenesulfonamide, commonly known as sulfanilamide, were
the ﬁrst effective chemotherapeutic agents to be widely used
for the treatment of bacterial infection in humans. They are
termed as sulfonamides, due to the presence of sulfonamide
(Maurya and Patel, 1999) group (–SO2NH2). The derivativeshe synthesized Schiff bases.
.) Found
C H
57.55 (57.63) 3.79 (3.95)
52.70 (52.83) 4.29 (4.40)
56.49 (56.52) 4.25 (4.35)
58.65 (58.70) 4.21 (4.35)
6) 68.29 (68.42) 4.30 (4.39)
Scheme 1 Synthesis of sulfaof sulfonamide exhibit a range of bioactivities, including anti-
angiogenic (Funahashi et al., 2002; Semba et al., 2004), anti-tu-
mor (Semba et al., 2004; Sawi´nski and Gdaniec, 2005), anti-
inﬂammatory and anti-analgesic (Chen et al., 2005), anti-tuber-
cular (Gadad et al., 2004), anti-glaucoma (Agrawal et al.,
2004), anti-HIV (Yeung et al., 2005), cytotoxic (Enc´ıo et al.,
2005), anti-microbial (Nieta et al., 2005) and anti-malarial
(Dom´ınguez et al., 2005) agents. The sulfonamide derivatives
are also known to exhibit a wide variety of pharmacological
activities (Yoshino et al., 1992; Toth et al., 1997; Medina
et al., 1999) through exchanges of different functional groups
without modiﬁcation of the structural –S(O)2N(H)– feature.
There are several reports on the Schiff bases complexes of dif-
ferent metals derived from sulfa drugs (Singh et al., 1999, 2000;
Mohamed and Gad-Elkareem, 2007; Sharaby, 2007; Mohamed/calc. (%) Color Decom. temp. (C)
N S
15.75 (15.82) 8.99 (9.04) Daﬀodil 260
17.52 (17.61) 9.95 (10.06) Daﬀodil 250
10.05 (10.14) 11.42 (11.59) Daﬀodil 210
15.12 (15.22) 8.62 (8.70) Primrose 265
6.02 (6.14) 6.92 (7.02) Canary yellow 260
















































































































































































































































































































































































































































































































































































































S1086 R.C. Maurya et al.and Sharaby, 2007; Mohamed et al., 2010; Maurya et al., 1994,
2007, 2010a,b, 2015a,b,c). The pronounced biological activity
of the metal complexes of Schiff bases derived from sulfa drugs
(Lal and Shukla, 1981; Jain and Chaturvedi, 1977) has led to
considerable interest in their coordination chemistry. The Schiff
bases derived by the condensation of sulfonamides with salicyl-
aldehyde are not only good complexing agents (Roy and Muk-
herjee, 1955; Jain and Chaturvedi,1975a,b, 1976), but also good
bacteriocides (Tiwari andMishra, 1980). Chelating ligands con-
taining O and N donor atoms (Maurya et al., 2003) show broad
biological activity and are of special interest because of the vari-
ety of ways in which they are bonded to metal ions (Syamal and
Maurya, 1989; Maurya and Maurya, 1995). Aromatic hydrox-
yaldehydes form stable complexes and the presence of a phenolic
hydroxyl group at their o-position imparts an additional donor
site of the molecule making it bidentate. Such a molecule coor-
dinates with the metal ion through the carbonyl oxygen and
deprotonated hydroxyl group. The chelating properties of Schiff
bases derived from o-hydroxyaldehydes and ketones are well
established (Maurya et al., 1993, 1995; Agarwal et al., 1994).
The coordination chemistry (Maurya, 2003) of vanadium
has acquired renewed interest since the discovery of vana-
dium in organisms such as certain ascidians and Amanita
muscaria mushrooms and as a constituent of the cofactors
in vanadate-dependent haloperoxidases and vanadium nitro-
genase (Butler, 1999; Little and Butler, 2001; Roson et al.,
1986; Rehder, 2003a,b). The role of vanadium complexes in
catalytically conducted redox reactions (Ligtenbarg et al.,
2003; Conte et al., 1997) potential pharmaceutical applica-
tions (Rehder, 2003a,b; Thompson and Orvig, 2004; Sakurai
et al., 2002; Rehder et al., 2002; Melchier et al., 1999; Clarke
et al., 1999) studies on the metabolism and detoxiﬁcation of
vanadium compounds under physiological conditions (Baran,
2000) and the stability and speciﬁcation of vanadium com-
plexes in bioﬂuids (Kiss et al., 2003, 2000) have also inﬂu-
enced the study of the coordination chemistry of
vanadium. Spectroscopic investigations have shown a distinct
preference of this metal center for N and/or O coordination
environment (Sivak et al., 1998; Asgedom et al., 1995). This
is consistent with the combination of hard acid (VO+2) and
hard (N and O ligands) bases (Sakurai et al., 1998). Some
vanadium complexes of O, N donor ligands have been re-
ported recently (Sutradhar et al., 2006; Miyazaki et al.,
2005; Sarkar and Pal, 2006; Hazara et al., 2007). Vanadium
complexes with Schiff base were reported to exhibit a range
of biological activities including anti-tuberculosis, antibacte-
rial, and antifungal properties, (Hashidhara and Goudar,
2000; Maqsood et al., 2006). In contrast to O, N donor li-
gands, complexes of vanadium containing sulfur functionality
have not received much attention (Samanta et al., 2003;
Maurya et al., 2002a,b, 2003; Monga et al., 2005). Vanadium
complexes having sulfur functionality have been found to be
orally active insulin-mimetic agents in the treatment of dia-
betic model animals (Kotosh et al., 2004). In vanadium
nitrogenase, the sulfur-vanadium bond has also been well
established (Eady and Legh, 1994).
It has also been recognized that vanadium as a micronutri-
ent, prevents the minor wear and tear of the essential critical
molecules of the cell like DNA, proteins, etc., in humans (Fen-
ech and Ferguson, 2001). Thus, it has a role in DNA mainte-
nance reactions and may protect the genomic instability that
may be leading to cancer (Ray et al., 2006).
Oxovanadium(IV) complexes of bioinorganic and medicinal relevance: Synthesis, characterization S1087A recent report from our laboratory, Maurya and Rajput
(2006) has reported the synthesis and characterization of four
new oxovanadium(IV) complexes, formed by the Schiff bases
derived from 3-methyl-1-phenyl-4-valeryl-2-pyrazolin-5-one
and the sulfa drugs. Another new series of four oxovana-
dium(IV) complexes involving O, N donor environment of
pyrazolone based sulfa drugs Schiff bases has also been re-
ported from our laboratory (Maurya et al., 2015a,b,c).
Considering the pronounced biological activity of the sulfa
drug Schiff base complexes, in view of the importance of vana-
dium compound, and also extending our search for more efﬁca-
cious vanadium compounds, a study was undertaken of the
coordination chemistry of oxovanadium(IV) complexes involv-
ing salicylaldehyde based sulfadrug Schiff bases viz., N-(salicy-
lidene)sulfadiazine (sal-sdzH, I), N-(salicylidene)sulfaguani
dine (sal-sgnH, II), N-(salicylidene)sulfanilamide(sal-snmH,




Vanadyl sulfate pentahydrate (Thomas Baker Ltd., Mumbai),
salicylaldehyde (E. Merck, Germany), sulfa drugs (sulfadia-
zine, sulfaguanidine, sulfanilamide, sulfamerazine, (Sigma
Chemicals Co., USA), daphsone (Fluka Chemie A.G., Switzer-
land), ethanol (Bengal Chemicals and Pharmaceuticals Ltd.,
Kolkata), were used as supplied. All other chemicals used were





m(C–O) (phenolic) m (V‚
1 [VO(sal-sdz)2(H2O)]ÆH2O 1600 1440 945
2 [VO(sal-sgn)2(H2O)]ÆH2O 1580 1440 940
3 [VO(sal-snm)2(H2O)]ÆH2O 1580 1440 940
4 [VO(sal-smr)2(H2O)]ÆH2O 1590 1450 930
5 [VO(sal-dadps)(H2O)]2Æ2H2O 1590 1450 980
Table 3 Some important IR spectral bands (cm1) of the synthesiz
S. no. Ligands m(C‚N) (azomethine) m(C–O) (phenoli
I sal-sdzH 1620 1490
II sal-sgnH 1620 1480
III sal-snmH 1615 1490
IV sal-smrH 1620 1490
V sal-dadpsH2 1620 14802.2. Synthesis of Schiff bases
The Schiff bases of sulfa drugs were prepared as follows: An
ethanolic solution (10 mL) of salicylaldehyde (0.244 g,
0.209 mL, 2 mmol) was added to the ethanolic solution
(20 mL) of sulfadiazine (0.500 g, 2 mmol), sulfanilamide
(0.344 g, 2 mmol), sulfaguanidine (0.428 g, 2 mmol), sulfamer-
izine (0.528 g, 2 mmol) or 4,40-diaminodiphenylsulfone
(0.248 g, 1 mmol). A colored solid mass separated out when
the mixture was heated at 80 C for 20 min. It was ﬁltered,
washed several times with ethanol and diethyl ether and subse-
quently, dried over anhydrous CaCl2 in a desiccator. The char-
acterization data of Schiff bases are given in Table 1.
2.3. Synthesis of complexes
The following general procedure was used in the synthesis of all
the complexes: A suspension of the Schiff base ligand sal-sdzH
(0.708 g, 2 mmol), sal-sgnH (0.636 g, 2 mmol), sal-snmH
(0.552 g, 2 mmol), sal-smrH (0.736 g, 2 mmol), and sal-dadpsH2
(0.456 g, 1 mmol) in the minimum quantity of DMF was mixed
with ethanol (20 mL). The resulting mixture was reﬂuxed with
stirring on a magnetic stirrer equipped with heater for 1 h to get
a clear solution. The salt of VOSO4Æ5H2O (0.253 g, 1 mmol) was
dissolved in ethanol-water (4:1, 5 mL) and the solution so ob-
tained was added to a hot, stirred ethanolic solution of the cor-
responding Schiff bases. The resulting solution was reﬂuxed for
10–12 h, and then concentrated to half of its volume. The result-
ing colored precipitate was then ﬁltered and washed several
timeswith ethanol to remove any unreacted ligand and themetal
salt. The product was dried in vacuo. The analytical data of the
complexes are given in Table 2.plexes.
O) m(OH)(H2O) m(NH)/NH2 ms(SO2) mas(SO2) m(V–O) m(V–N)
3400 3100 1160 1340 580 450
3400 3360 1150 1330 580 450
3360 3240
3400 3350 1150 1330 580 460
3350 3240
3500 3240 1170 1325 580 470
3380
3460 – 1150 1300 550 450
3380
ed Schiff bases.
c) m(NH)/NH2 m(OH) (phenolic) mas(SO2) ms(SO2)
3100 3480 1340 1160
3353 3420 1300 1170
3240
3340 3480 1310 1160
3240
3240 3340 1310 1160
– 3400 (br) 1320 1150
S1088 R.C. Maurya et al.2.4. Analyses
Carbon, hydrogen and nitrogen were determined micro-ana-
lytically at SAIF, Indian Institute of Technology, Mumbai.
The vanadium content of each of the complexes was deter-
mined as follows. A 100 mg of sample of the compound was
placed in a silica crucible, decomposed by gentle heating and
then adding 1–2 mL of concentrated HNO3, 2–3 times. An
orangish mass (V2O5) was obtained after decomposing and
complete drying. It was dissolved in the minimum amount of
dilute H2SO4, and the solution so obtained was diluted with
distilled water to 100 mL in a measuring ﬂask. The vanadium
content of each of the complexes was determined volumetri-
cally using decinormal KMnO4 solution as an oxidizing agent
in the presence of sulfurous acid. The amount of vanadium in
the sample solution was calculated using the standard
(Furman, 1962) relationship: 1 mL of 0.1 N KMnO4 =
5.094 mg vanadium.
2.5. Physical methods
The following physical methods were used in the present
investigation. The solid-state infrared spectra were obtainedFigure 1 IR spectr
Figure 2 IR spectrum of [VOusing KBr pellets with a Perkin–Elmer model 1620 FT-IR
spectrophotometer at the Central Drug Research Institute,
Lucknow. Thermogravimetry of the complexes was per-
formed on a Perkin–Elmer Thermoanalyser at S. A. I. F., In-
dian Institute of Technology, Mumbai. Electronic spectra
were recorded on an ATI Unicam UV-1-100 UV/Visible
Spectrophotometer in our laboratory. Conductance measure-
ments were made in DMF solution using a Toshniwal con-
ductivity bridge and dip-type cell with a smooth platinum
electrode of cell constant 1.02. Magnetic measurements were
done by a vibrating sample magnetometer at the Regional
Sophisticated Instrumentation Centre, Indian Institute of
Technology, Chennai. The decomposition temperatures of
the complexes were recorded by an electrically operated melt-
ing point apparatus (Kumar Industries, Mumbai) of heating
capacity up to 360 C. The X-Band and EPR spectra of the
complexes were measured on a Bruker ESP X-Band EPR
spectrometer using powdered samples at the Regional Sophis-
ticated Instrumentation Centre, Indian Institute of Technol-
ogy, Chennai. The FAB mass spectrum of a representative
complex was recorded on a JEOL SX 102/DA-6000 Mass
Spectrometer/Data system using Argon/Xenon (6KV,
10 mA) as the FAB gas. The accelerating voltage wasum of sal-snmH.
(sal-snm)(H2O)]ÆH2O (3).
Figure 4 TG curve of [VO(sal-dadps)(H2O)]2Æ2H2O (5).
Oxovanadium(IV) complexes of bioinorganic and medicinal relevance: Synthesis, characterization S108910 KV and the spectrum was recorded at room temperature
and m-nitrobenzyl alcohol (NBA) was used as the matrix.
2.6. 3D Molecular modeling studies
The 3D molecular modeling of one of the synthesized com-
pound was carried out on CS Chem 3D Ultra Molecular Mod-
eling and Analysis Program (http://www.cambridgesoft.com).
It is an interactive graphics program that allows rapid struc-
ture building, geometry optimization and molecular display.
It has the ability to handle transition metal compounds.
3. Results and discussion
The ﬁve sulfa drugs based Schiff base ligands, sal-sdzH, sal-
sgnH, sal-snmH, sal-smrH and sal-dadpsH2 were prepared
by the interaction of salicylaldehyde and sulfa drugs in ethanol
according to Scheme 1.
The micro-analytical data of these Schiff base ligands along
with physical properties are given in Table 1. Some important
IR spectral bands of these ligands are given in Table 3. The
formation of these Schiff base ligands can be conﬁrmed by
the appearance of a strong band for m(C‚N) (Hazara et al.,
2007; Hashidhara and Goudar, 2000) (azomethine) at 1615–
1620 cm1. The IR spectra of these ligands also exhibit rele-
vant bands for m(OH) (phenolic), m(C–O) (phenolic), m(NH/
NH2), mas(SO2) and ms(SO2) (see Table 3), which also support
the formation of Schiff base ligands.
The oxovanadium(IV) complexes were prepared according
to the following equations:




Where, LH = sal-sdzH (1), sal-sgnH (2), sal-snmH (3) or sal-
smrH (4) and




 ðH2OÞ2  2H2Oð5Þ þ 2H2SO4
The resulting complexes are soluble in DMF and DMSO, par-
tially soluble in acetonitrile and insoluble in ethanol, methanolFigure 3 TG curve of [VOand carbon tetrachloride. Their physical properties are given in
Table 2. The complexes were characterized by the following
studies:3.1. Infrared spectral studies
All the ligands except (sal-dadpsH2 and sal-snmH) contain ﬁve
donor sites: (i) the phenolic oxygen, (ii) the azomethine
nitrogen, (iii) sulfonamide oxygens, (iv) sulfonamide nitrogen,
(v) ring nitrogens in the case of sal-sdzH and sal-smrH or ami-
no nitrogen in the case of sal-sgnH. The ligand, sal-snmH con-
tains only four potential donor sites, (i)–(iv) given above. The
remaining ligand, sal-dadpsH2 possesses ﬁve potential donor
sites (i) two azomethine nitrogens, (ii) two phenolic oxygens,
(iii) sulfonamide oxygens. All the Schiff base ligands show a
sharp and strong band due to m(C‚N) of the azomethine
group at 1615–1620 cm1. The observed low energy shift
(Maurya and Rajput, 2006) of this band in the complexes
appearing at 1580–1600 cm1, suggests the coordination of
azomethine nitrogen to the metal center. This is further sup-
ported by the appearance of a new band at 450–470 cm1
due to the m(V–N) band (Maurya et al., 2015a,b,c).(sal-sdz)(H2O)]ÆH2O (1).
Figure 6 ESR spectrum of [VO(sal-dadps)(H2O)]2Æ2H2O (5).
Figure 5 ESR spectrum of [VO(sal-sdz)(H2O)]ÆH2O (1).
S1090 R.C. Maurya et al.
Figure 7 Mass spectrum of [VO(sal-sdz)(H2O)]ÆH2O (1).
Table 5 Electronic Spectral Peaks of the Synthesized Complexes.
Comp. no. Complex kmax (nm) e (liter mol
1 cm1) Peak assignments
1 [VO(sal-sdz)2(H2O)]ÆH2O 281 2446 Charge Transfer Transition
303 2404 Charge Transfer Transition
320 2340 Charge Transfer Transition
430 1137 b2 ! 1a1
2 [VO(sal-sgn)2(H2O)]ÆH2O 288 4770 Charge Transfer Transition
304 3947 Charge Transfer Transition Charge
322 3910 Transfer Transition
339 290 b2 ! 1a1
426 214 b2 ! b1
3 [VO(sal-snm)2(H2O)]ÆH2O 285 2230 Charge Transfer Transition
310 2170 Charge Transfer Transition Charge
330 2125 Transfer Transition
400 750 b2 ! 1a1
4 [VO(sal-smr)2(H2O)]ÆH2O 300 2247 Charge Transfer Transition
315 2183 Charge Transfer Transition Charge
325 2119 Transfer Transition
380 855 b2 ! 1a1
5 [VO(sal-dadps)(H2O)]2Æ2H2O 288 2340 Charge Transfer Transition
310 2204 Charge Transfer Transition
335 2040 Charge Transfer Transition
415 650 b2 ! 1a1
Oxovanadium(IV) complexes of bioinorganic and medicinal relevance: Synthesis, characterization S1091The m(NH) mode of the sulfonamide group/amino group in
the uncoordinated Schiff bases remains unchanged in the spec-
tra of their complexes (see Tables 3 and 4). This suggests that
the sulfonamide nitrogen or amino group is not taking part in
coordination. The bands, in these ligands, due to mas(SO2) and
ms(SO2) appear at 1300–1340 and 1150–1170 cm
1, respec-
tively. These remain almost unchanged in the spectra of
complexes, indicating that sulfonamide oxygens are not partic-
ipating in coordination. This is consistent with our previous
observation (Maurya et al., 2003a) in sulfa drug based Schiff
bases.
The characteristic phenolic m(OH) mode in all the ligands
due to the presence of a hydroxyl group at the ortho position,
was observed at 3340–3480 cm1. A medium band at 1480–
1490 cm1 due to m(C–O) of the phenolic group was also ob-
served in these ligands. The band due to the phenolic (OH)group of these ligands should be absent in all of the complexes
under study to indicate the coordination of the phenolic oxy-
gen, after deprotonation, to the metal ion. But due to the pres-
ence of a broad band (vide infra) for lattice and coordinated
water, it is difﬁcult to conﬁrm with certainty the coordination
of the phenolic oxygen after deprotonation. However, such
coordination is supported by the observed shift of the phenolic
m(C–O) band to a lower wave number (Maurya et al., 2008a,b)
at 1440–1450 cm1 in the complexes. The coordination of phe-
nolic oxygen is further supported by the appearance of a non
ligand band at 550–580 cm1, due to m(V–O) (Maurya et al.,
2003b) in the complexes. The band due to m(C‚N) ring
appearing at 1580 and 1588 cm1 in the ligands, sal-sdzH
and sal-smrH remains unchanged in the respective complexes.
This suggests that ring nitrogens of the ligand are not taking
part in coordination. This is logical in terms of six-member
Figure 8 Electronic spectrum of [VO(sal-sdz)(H2O)]ÆH2O (1).
Figure 10 3D-Structur
Figure 9 Structure of bis(picolinato)oxovanadium(IV).
S1092 R.C. Maurya et al.chelate ring formation including metal on account of the
bidentate coordination of azomethine nitrogen and phenyl
oxygen from the ortho position.
The presence of lattice/coordinated water (Maurya et al.,
2003a,b,c,d) in the complexes is revealed by the presence of
either a broad band at 3400 cm1 or two weak bands at
3400–3500 and 3350–3380 cm1.
Most of the oxovanadium(IV) complexes display a strong
band near 1000 cm1 assignable to m(V‚O) (Selbin, 1966).
Contrary to this, several oxovanadium(IV) complexes have
been reported in which this stretching mode appears at quite
lower (Maurya and Rajput, 2006; Maurya et al., 2001) wave
numbers around 900 cm1 due to the presence of a   V‚O  
V‚O   chain structure, which is formed by the interaction of
vanadyl oxygen of one molecule with a vanadium metal in
another molecule (Boas and Pessoa, 1987). In the complexes
presented here, m(V‚O) is found at 930–980 cm1. This sug-
gests the absence of a   V‚O  V‚O   chain. The presence
of a coordinated water molecule in this complex (discussed
above) supports this fact. The IR spectra of the Schiff base
ligand (sal-snmH, III) and its complex, [VO(sal-snm)(H2O)]Æ
H2O (3) are given in Figs. 1 and 2, respectively.
3.2. Thermogravimetric studies
Thermogravimetric analysis of two representative compounds,
namely [VO(sal-sdz)2(H2O)]ÆH2O (1) and [VO(sal-dadps)
(H2O)]2Æ2H2O (5) were recorded in the temperature range from
ambient to 1000 C at the heating rate of 15 C/min. The
compound (1) exhibits a weight loss of 4.66% at approximatelye of compound (3).
Figure 11 3D-Structure of compound (5).
Oxovanadium(IV) complexes of bioinorganic and medicinal relevance: Synthesis, characterization S1093277.00 C (calcd. wt. loss for two moles of H2O, 4.45%)
corresponding to the removal of two molecules of water. As
the compound starts loosing weight right from about
50.00 C, one water molecule may be taken as lattice water
and the other as the coordinated water. The second weight loss
observed at 490.00 C is found to be 51.48%against a calculatedTable 6a1 Various bond lengths of compound [VO(sal-snm)2(H2O)
S. no. Atoms Actual bond length Optimal bond length
1 O(42)–H(44) 0.942 0.942
2 O(42)–H(43) 0.942 0.942
3 N(41)–H(65) 1.02 1.02
4 N(41)–H(64) 1.02 1.02
5 S(38)–N(41) 1.696
6 S(38)–O(40) 1.45 1.45
7 S(38)–O(39) 1.45 1.45
8 N(37)–H(63) 1.02 1.02
9 N(37)–H(62) 1.02 1.02
10 S(34)–N(37) 1.696
11 S(34)–O(36) 1.45 1.45
12 S(34)–O(35) 1.45 1.45
13 C(31)–H(33) 1.1 1.1
14 C(31)–N(32) 2.3057 1.26
15 C(30)–H(61) 1.1 1.1
16 C(29)–H(60) 1.1 1.1
17 C(29)–C(30) 1.337 1.42
18 C(28)–H(59) 1.1 1.1
19 C(28)–C(29) 1.4345 1.42
20 C(27)–H(58) 1.1 1.1
21 C(27)–C(28) 1.337 1.42
22 C(25)–C(27) 1.337 1.42
23 C(25)–O(26) 1.355 1.355
24 C(24)–C(31) 1.337 1.503
25 C(24)–C(30) 1.337 1.42
26 C(24)–C(25) 1.337 1.42
27 C(21)–H(23) 1.1 1.1
28 C(21)–N(22) 1.2782 1.26
29 C(20)–H(57) 1.1 1.1
30 C(19)–H(56) 1.1 1.1
31 C(19)–C(20) 1.337 1.42
32 C(18)–H(55) 1.1 1.1
33 C(18)–C(19) 1.337 1.42
34 C(17)–H(54) 1.1 1.1
35 C(17)–C(18) 1.337 1.42weight loss of 48.08% corresponding to the elimination of one
ligand moiety. The ﬁnal weight loss at approximately
573.13 C has been found to be 90.54% against a calculated
weight loss of 91.72% involving the removal of another
ligand moiety. The ﬁnal residue attaining a constant weight
over 600.00 C (obsd. = 9.46%) corresponds to V2O5]ÆH2O (3).
S. No. Atoms Actual bond length Optimal bond length
36 C(15)–C(17) 1.337 1.42
37 C(15)–O(16) 1.355 1.355
38 C(14)–C(21) 1.337 1.503
39 C(14)–C(20) 1.337 1.42
40 C(14)–C(15) 1.337 1.42
41 C(13)–S(38) 1.79 –
42 C(12)–H(53) 1.1 1.1
43 C(12)–C(13) 1.3949 1.42
44 C(11)–H(52) 1.1 1.1
45 C(11)–C(12) 1.3948 1.42
46 C(10)–N(32) 1.26 1.456
47 C(10)–C(11) 1.3948 1.42
48 C(9)–H(51) 1.1 1.1
49 C(9)–C(10) 1.3949 1.42
50 C(8)–H(50) 1.1 1.1
51 C(13)–C(8) 1.3948 1.42
52 C(8)–C(9) 1.3948 1.42
53 C(7)–S(34) 1.79 –
54 C(6)–H(49) 1.1 1.1
55 C(6)–C(7) 1.3949 1.42
56 C(5)–H(48) 1.1 1.1
57 C(5)–C(6) 1.3948 1.42
58 N(22)–C(4) 1.26 1.456
59 C(4)–C(5) 1.3948 1.42
60 C(3)–H(47) 1.1 1.1
61 C(3)–C(4) 1.3949 1.42
62 C(2)–H(46) 1.1 1.1
63 C(7)–C(2) 1.3948 1.42
64 C(2)–C(3) 1.3948 1.42
65 V(1)–O(45) 1.5996 –
66 V(1)–O(42) 1.86 –
67 O(16)–V(1) 1.86 –
68 N(22)–V(1) 1.896 –
69 N(32)–V(1) 1.896 –
70 O(26)–V(1) 1.86 –
Table 6a2 Various bond angles of compound [VO(sal-snm)2(H2O)]ÆH2O (3).
S. no. Atoms Actual bond angles Optimal bond angles S. No. Atoms Actual bond angles Optimal bond angles
1 H(65)–N(41)–H(64) 119.9998 104.5 62 H(55)–C(18)–C(19) 119.9998 120
2 H(65)–N(41)–S(38) 120.0002 – 63 H(55)–C(18)–C(17) 119.9999 120
3 H(64)–N(41)–S(38) 120 – 64 C(19)–C(18)–C(17) 120.0003 –
4 H(63)–N(37)–H(62) 119.9999 104.5 65 H(54)–C(17)–C(18) 119.9999 120
5 H(63)–N(37)–S(34) 119.9995 – 66 H(54)–C(17)–C(15) 120.0003 120
6 H(62)–N(37)–S(34) 120.0006 – 67 C(18)–C(17)–C(15) 119.9997 –
7 H(60)–C(29)–C(30) 122.2431 120 68 C(15)–O(16)–V(1) 109.4996 –
8 H(60)–C(29)–C(28) 122.2429 120 69 H(57)–C(20)–C(19) 120 120
9 C(30)–C(29)–C(28) 115.514 – 70 H(57)–C(20)–C(14) 120.0004 120
10 H(59)–C(28)–C(29) 122.2423 120 71 C(19)–C(20)–C(14) 119.9996 –
11 H(59)–C(28)–C(27) 122.2421 120 72 C(17)–C(15)–O(16) 115.6987 124.3
12 C(29)–C(28)–C(27) 115.5156 – 73 C(17)–C(15)–C(14) 120.0004 120
13 H(61)–C(30)–C(29) 120 120 74 O(16)–C(15)–C(14) 124.2985 124.3
14 H(61)–C(30)–C(24) 119.9997 120 75 N(37)–S(34)–O(36) 109.4417 –
15 C(29)–C(30)–C(24) 120.0003 – 76 N(37)–S(34)–O(35) 109.4418 –
16 H(58)–C(27)–C(28) 119.9995 120 77 N(37)–S(34)–C(7) 109.5205 –
17 H(58)–C(27)–C(25) 120.0002 120 78 O(36)–S(34)–O(35) 109.4996 116.6
18 C(28)–C(27)–C(25) 120.0003 – 79 O(36)–S(34)–C(7) 109.4619 –
19 C(27)–C(25)–O(26) 115.6993 124.3 80 O(35)–S(34)–C(7) 109.462 –
20 C(27)–C(25)–C(24) 119.9989 120 81 S(34)–C(7)–C(6) 120.0002 –
21 O(26)–C(25)–C(24) 124.2997 124.3 82 S(34)–C(7)–C(2) 120.0002 –
22 N(41)–S(38)–O(40) 109.4417 – 83 C(6)–C(7)–C(2) 119.9996 120
23 N(41)–S(38)–O(39) 109.442 – 84 H(49)–C(6)–C(7) 120.0013 120
24 N(41)–S(38)–C(13) 109.5201 – 85 H(49)–C(6)–C(5) 120.0012 120
25 O(40)–S(38)–O(39) 109.4997 116.6 86 C(7)–C(6)–C(5) 119.9976 –
26 O(40)–S(38)–C(13) 109.4618 – 87 H(46)–C(2)–C(7) 119.9986 120
27 O(39)–S(38)–C(13) 109.462 – 88 H(46)–C(2)–C(3) 119.9985 120
28 S(38)–C(13)–C(12) 120.0007 – 89 C(7)–C(2)–C(3) 120.0029 –
29 S(38)–C(13)–C(8) 120.0001 – 90 H(48)–C(5)–C(6) 119.9989 120
30 C(12)–C(13)–C(8) 119.9992 120 91 H(48)–C(5)–C(4) 119.9993 120
31 H(53)–C(12)–C(13) 120.0008 120 92 C(6)–C(5)–C(4) 120.0018 –
32 H(53)–C(12)–C(11) 120.0013 120 93 H(47)–C(3)–C(4) 120.0015 120
33 C(13)–C(12)–C(11) 119.9979 94 H(47)–C(3)–C(2) 120.0016 120
34 H(50)–C(8)–C(13) 119.9987 120 95 C(4)–C(3)–C(2) 119.9969 –
35 H(50)–C(8)–C(9) 119.9986 120 96 C(21)–C(14)–C(20) 119.9989 120
36 C(13)–C(8)–C(9) 120.0028 – 97 C(21)–C(14)–C(15) 119.9987 120
37 H(52)–C(11)–C(12) 119.9989 120 98 C(20)–C(14)–C(15) 119.9999 120
38 H(52)–C(11)–C(10) 119.9993 120 99 H(23)–C(21)–N(22) 119.12 116.5
39 C(12)–C(11)–C(10) 120.0017 – 100 H(23)–C(21)–C(14) 119.12 120
40 H(51)–C(9)–C(10) 120.0017 120 101 N(22)–C(21)–C(14) 121.76 123.5
41 H(51)–C(9)–C(8) 120.0011 120 102 N(22)–C(4)–C(5) 119.9993 120
42 C(10)–C(9)–C(8) 119.9971 – 103 N(22)–C(4)–C(3) 119.9994 120
43 C(31)–C(24)–C(30) 119.9988 120 104 C(5)–C(4)–C(3) 120.0013 120
44 C(31)–C(24)–C(25) 119.9989 120 105 C(21)–N(22)–C(4) 119.1178 –
45 C(30)–C(24)–C(25) 119.9998 120 106 C(21)–N(22)–V(1) 121.7647 –
46 H(33)–C(31)–N(32) 105.7245 116.5 107 C(4)–N(22)–V(1) 119.1175 –
47 H(33)–C(31)–C(24) 105.7246 120 108 O(45)–V(1)–O(42) 135.6046 –
48 N(32)–C(31)–C(24) 148.5509 123.5 109 O(45)–V(1)–O(16) 174.2007 –
49 N(32)–C(10)–C(11) 119.9995 120 110 O(45)–V(1)–N(22) 89.1053 –
50 N(32)–C(10)–C(9) 119.9992 120 111 O(45)–V(1)–N(32) 95.7292 –
51 C(11)–C(10)–C(9) 120.0012 120 112 O(45)–V(1)–O(26) 65.4876 –
52 H(44)–O(42)–H(43) 120.0002 – 113 O(42)–V(1)–O(16) 44.9999 –
53 H(44)–O(42)–V(1) 120.0001 – 114 O(42)–V(1)–N(22) 135 –
54 H(43)–O(42)–V(1) 119.9997 – 115 O(42)–V(1)–N(32) 90.0001 –
55 C(31)–N(32)–C(10) 148.1512 – 116 O(42)–V(1)–O(26) 89.9998 –
56 C(31)–N(32)–V(1) 63.698 – 117 O(16)–V(1)–N(22) 90.0001 –
57 C(10)––N(32)–V(1) 148.1508 – 118 O(16)–V(1)–N(32) 90.0002 –
58 C(25)–O(26)–V(1) 109.5002 – 119 O(16)–V(1)–O(26) 109.4998 –
59 H(56)–C(19)–C(20) 119.9995 120 120 N(22)–V(1)–N(32) 90.0001 –
60 H(56)–C(19)–C(18) 120.0004 120 121 N(22)–V(1)–O(26) 109.5001 –
61 C(20)–C(19)–C(18) 120.0001 – 122 N(32)–V(1)–O(26) 151.8308 –
S1094 R.C. Maurya et al.(calcd. =10.25%) (Maurya et al., 2015a,b,c). This weight loss
data, thus, agree well with the IR results for this complex. The
thermogram of compound, [VO(sal-sdz)2(H2O)]ÆH2O (1) is
given in Fig. 3.
The compound (5) shows a weight loss of 6.43% at
337.00 C (calcd. wt. loss for four moles of water, 6.46%) cor-
responding to the removal of four water molecules similar to
compound (1). It also starts loosing weight right from
50.00 C. This suggests that two water molecules are lattice
water and other two are coordinated. Taking the dimericstructure of the compound into account (vide infra), this seems
to be logical. Another weight loss of 45.42% by this compound
was noticed around 550.00 C (calculated wt. loss of one li-
gand moiety, 47.22%), suggesting the removal of one ligand
moiety from the complex. The ﬁnal weight loss of 85.97% ob-
served at 700.00 C (calcd. wt. loss for another ligand moi-
ety, 87.98%), indicates the elimination of second ligand
moiety from the complex. The ﬁnal residue attaining a con-
stant weight over 750 C corresponds to (obsd. = 14.03%)
V2O5 (calculated = 14.89%) (Maurya et al., 2015a,b,c). The
Table 6b1 Various bond lengths of compound [VO(sal-dadps)(H2O)]2Æ2H2O (5).
S. no. Atoms Actual bond length Optimal Bond Length S. No. Atoms Actual bond length Optimal bond length
1 O(76)–H(78) 0.942 0.942 63 S(36)–C(45) 1.79 –
2 O(76)–H(77) 0.942 0.942 64 S(36)–C(39) 1.79 –
3 O(75)–H(80) 0.942 0.942 65 S(36)–O(38) 1.45 1.45
4 O(75)–H(79) 0.942 0.942 66 S(36)–O(37) 1.45 1.45
5 V(72)–O(75) 1.86 – 67 O(34)–V(72) 1.86 –
6 V(72)–O(74) 1.5996 – 68 C(33)–H(35) 1.1 1.1
7 V(71)–O(76) 1.86 – 69 O(34)–C(32) 1.3722 1.355
8 V(71)–O(73) 1.5996 – 70 C(31)–H(96) 1.1 1.1
9 O(69)–V(72) 1.86 – 71 C(31)–C(32) 1.337 1.42
10 C(68)–H(70) 1.1 1.1 72 C(30)–H(95) 1.1 1.1
11 O(69)–C(67) 3.4681 1.355 73 C(30)–C(31) 1.337 1.42
12 C(66)–H(112) 1.1 1.1 74 C(29)–H(94) 1.1 1.1
13 C(66)–C(67) 1.337 1.42 75 C(29)–C(30) 2.6164 1.42
14 C(65)–H(111) 1.1 1.1 76 C(28)–H(93) 1.1 1.1
15 C(65)–C(66) 1.337 1.42 77 C(28)–C(29) 1.337 1.42
16 C(64)–H(110) 1.1 1.1 78 C(27)–C(33) 1.337 1.503
17 C(64)–C(65) 1.6862 1.42 79 C(32)–C(27) 1.337 1.42
18 C(63)–H(109) 1.1 1.1 80 C(27)–C(28) 1.337 1.42
19 C(63)–C(64) 1.337 1.42 81 N(26)–V(72) 1.896 –
20 C(62)–C(68) 1.337 1.503 82 N(26)–C(33) 1.26 1.26
21 C(67)–C(62) 1.337 1.42 83 C(24)–H(25) 1.1 1.1
22 C(62)–C(63) 1.337 1.42 84 O(23)–V(71) 1.86 –
23 N(61)–V(72) 1.896 85 N(22)–V(71) 1.896 –
24 N(61)–C(68) 1.26 1.26 86 N(22)–C(24) 1.26 1.26
25 C(59)–H(60) 1.1 1.1 87 C(21)–O(23) 1.355 1.355
26 O(58)–V(71) 1.86 88 C(20)–H(92) 1.1 1.1
27 N(57)–V(71) 1.896 89 C(20)–C(21) 1.337 1.42
28 N(57)–C(59) 1.26 1.26 90 C(19)–H(91) 1.1 1.1
29 C(56)–O(58) 1.355 1.355 91 C(19)–C(20) 1.337 1.42
30 C(55)–H(108) 1.1 1.1 92 C(18)–H(90) 1.1 1.1
31 C(55)–C(56) 1.337 1.42 93 C(18)–C(19) 1.5533 1.42
32 C(54)–H(107) 1.1 1.1 94 C(17)–H(89) 1.1 1.1
33 C(54)–C(55) 1.337 1.42 95 C(17)–C(18) 1.337 1.42
34 C(53)–H(106) 1.1 1.1 96 C(16)–C(24) 1.4475 1.503
35 C(53)–C(54) 1.3514 1.42 97 C(21)–C(16) 1.337 1.42
36 C(52)–H(105) 1.1 1.1 98 C(16)–C(17) 1.337 1.42
37 C(52)–C(53) 1.337 1.42 99 C(15)–H(88) 1.1 1.1
38 C(51)–C(59) 4.3751 1.503 100 C(14)–H(87) 1.1 1.1
39 C(56)–C(51) 1.337 1.42 101 C(14)–C(15) 1.337 1.42
40 C(51)–C(52) 1.337 1.42 102 C(13)–N(26) 1.26 1.456
41 C(50)–H(104) 1.1 1.1 103 C(13)–C(14) 1.337 1.42
42 C(49)–H(103) 1.1 1.1 104 C(12)–H(86) 1.1 1.1
43 C(49)–C(50) 2.1434 1.42 105 C(12)–C(13) 1.337 1.42
44 C(48)–N(61) 1.26 1.456 106 C(11)–H(85) 1.1 1.1
45 C(48)–C(49) 1.337 1.42 107 C(11)–C(12) 1.3373 1.42
46 C(47)–H(102) 1.1 1.1 108 C(10)–C(15) 1.337 1.42
47 C(47)–C(48) 1.337 1.42 109 C(10)–C(11) 1.337 1.42
48 C(46)–H(101) 1.1 1.1 110 C(9)–H(84) 1.1 1.1
49 C(46)–C(47) 1.8878 1.42 111 C(8)–H(83) 1.1 1.1
50 C(45)–C(50) 1.337 1.42 112 C(8)–C(9) 1.337 1.42
51 C(45)–C(46) 1.337 1.42 113 N(22)–C(7) 1.26 1.456
52 C(44)–H(100) 1.1 1.1 114 C(7)–C(8) 1.337 1.42
53 C(43)–H(99) 1.1 1.1 115 C(6)–H(82) 1.1 1.1
54 C(43)–C(44) 1.337 1.42 116 C(6)–C(7) 1.337 1.42
55 N(57)–C(42) 1.26 1.456 117 C(5)–H(81) 1.1 1.1
56 C(42)–C(43) 1.337 1.42 118 C(5)–C(6) 1.3373 1.42
57 C(41)–H(98) 1.1 1.1 119 C(4)–C(9) 1.337 1.42
58 C(41)–C(42) 1.337 1.42 120 C(4)–C(5) 1.337 1.42
59 C(40)–H(97) 1.1 1.1 121 S(1)–C(10) 1.79 –
60 C(40)–C(41) 1.3371 1.42 122 S(1)–C(4) 1.79 –
61 C(39)–C(44) 1.337 1.42 123 S(1)–O(3) 1.45 1.45
62 C(39)–C(40) 1.337 1.42 124 S(1)–O(2) 1.45 1.45
Oxovanadium(IV) complexes of bioinorganic and medicinal relevance: Synthesis, characterization S1095thermogram of compound, [VO(sal-dadps)(H2O)]2Æ2H2O (5) is
given in Fig. 4.
3.3. ESR spectral studies
The liquid nitrogen temperature (LNT) X-Band ESR spectra
of two representative compounds namely [VO(sal-
sdz)2(H2O)]ÆH2O (1) and [VO(sal-dadps)(H2O)]2Æ2H2O (5)
were recorded in powder form using TCNE (tetracynoethyl-
ene) as a marker. Both gk and g^ components were resolved
in compound (1). The observed spectral parameters for thiscompound are: g^= 1.976, gk= 1.966, gav = 1.969,
A^= 80 G, Ak= 70 G and Aav = 76.66. The deviation of
gk, g^ and gav values in the complex from the free ion value
of 2.0027 suggests that the resulting complex is covalent (Dutta
and Syamal, 1993) in nature. Furthermore, the feature of the
spectrum of the complex is indicative of its monomeric struc-
ture (Maurya et al., 2002a,b).
The ESR spectrum of compound (5) does not exhibit usual
shape of a paramagnetic sample. Instead, it shows a zigzag
straight-line curve. This is most probably due to the partial
pairing of two unpaired electron spins on two oxovanadium
S1096 R.C. Maurya et al.centers because of dimer formation involving ligand bridging.
The ESR spectra of compound (1) and (5) are given in Figs. 5
and 6, respectively.3.4. Mass spectral studies
In the FAB mass spectrum (Fig. 7) of a representative complex
[VO(sal-sdz)2(H2O)]ÆH2O the matrix peaks were supposed to
appear at m/z 136, 137, 154, 289, 307 in the absence of anyTable 6b2 Various bond angles of compound [VO(sal-dadps)(H2O
S. no. Atoms Actual bond angles Optimal bond angles
1 H(111)–C(65)–C(66) 126.8897 120
2 H(111)–C(65)–C(64) 126.8887 120
3 C(66)–C(65)–C(64) 106.2217 –
4 H(110)–C(64)–C(65) 126.8892 120
5 H(110)–C(64)–C(63) 126.8892 120
6 C(65)–C(64)–C(63) 106.2216 –
7 H(112)–C(66)–C(67) 119.9995 120
8 H(112)–C(66)–C(65) 120.0002 120
9 C(67)–C(66)–C(65) 120.0003 –
10 O(69)–C(67)–C(66) 111.531 124.3
11 O(69)–C(67)–C(62) 128.4687 124.3
12 C(66)–C(67)–C(62) 119.9986 120
13 H(109)–C(63)–C(64) 120 120
14 H(109)–C(63)–C(62) 119.9998 120
15 C(64)–C(63)–C(62) 120.0002 –
16 H(107)–C(54)–C(55) 120.2968 120
17 H(107)–C(54)–C(53) 120.297 120
18 C(55)–C(54)–C(53) 119.4062 –
19 H(106)–C(53)–C(54) 120.3246 120
20 H(106)–C(53)–C(52) 120.3253 120
21 C(54)–C(53)–C(52) 119.3502 –
22 H(108)–C(55)–C(56) 120.0002 120
23 H(108)–C(55)–C(54) 120 120
24 C(56)–C(55)–C(54) 119.9999 –
25 O(58)–C(56)–C(55) 115.699 124.3
26 O(58)–C(56)–C(51) 124.3001 124.3
27 C(55)–C(56)–C(51) 119.9989 120
28 H(105)–C(52)–C(53) 119.9996 120
29 H(105)–C(52)–C(51) 120.0002 120
30 C(53)–C(52)–C(51) 120.0002 –
31 C(68)–C(62)–C(67) 119.9999 120
32 C(68)–C(62)–C(63) 119.9988 120
33 C(67)–C(62)–C(63) 119.9988 120
34 H(70)–C(68)–C(62) 119.9999 120
35 H(70)–C(68)–N(61) 120.0001 116.5
36 C(62)–C(68)–N(61) 120 123.5
37 H(103)–C(49)–C(50) 137.9078 120
38 H(103)–C(49)–C(48) 137.9074 120
39 C(50)–C(49)–C(48) 84.1848 –
40 N(61)–C(48)–C(49) 119.9999 120
41 N(61)–C(48)–C(47) 119.9986 120
42 C(49)–C(48)–C(47) 119.999 120
43 H(102)–C(47)–C(48) 144.7547 120
44 H(102)–C(47)–C(46) 144.7544 120
45 C(48)–C(47)–C(46) 70.4909 –
46 H(104)–C(50)–C(49) 145.0758 120
47 H(104)–C(50)–C(45) 145.0758 120
48 C(49)–C(50)–C(45) 69.8484 –
49 H(101)–C(46)–C(47) 137.5888 120
50 H(101)–C(46)–C(45) 137.5891 120
51 C(47)–C(46)–C(45) 84.8221 –
52 C(50)–C(45)–C(46) 119.9986 120
53 C(50)–C(45)–S(36) 119.9987 –
54 C(46)–C(45)–S(36) 120.0003 –
55 H(100)–C(44)–C(43) 119.9998 120
56 H(100)–C(44)–C(39) 119.9998 120
57 C(43)–C(44)–C(39) 120.0004 –
58 C(45)–S(36)–C(39) 109.5003 –
59 C(45)–S(36)–O(38) 109.4618 –
60 C(45)–S(36)–O(37) 109.442 –
61 C(39)–S(36)–O(38) 109.4615 –
62 C(39)–S(36)–O(37) 109.4419 –
63 O(38)–S(36)–O(37) 109.5197 116.6metal ion. If metal ions are present, these peaks may be shifted
accordingly. Besides matrix peaks at 136, 137, 154, 289 and
307 m/z, and other spectral peaks were observed at 381, 419,
460, 613, 773 m/z in the compound in question which are most
probably due to following types of ion associations:
(i) [Molecular ion]+ (772.94)  *[C4N3H4SO2]+
(157)  **[C10N3H9SO2]+ (235) = 380.94 (381).
(ii) [sal-sdz]+ (353) + [V‚O]+ (66.94)  H+ = 418.94
(419).)]2Æ2H2O (5).
S. No. Atoms Actual bond angles Optimal bond angles
111 O(75)–V(72)–O(74) 82.1813 –
112 O(75)–V(72)–O(69) 88.922 –
113 O(75)–V(72)–N(61) 91.0778 –
114 O(75)–V(72)–O(34) 97.8186 –
115 O(75)–V(72)–N(26) 172.1064 –
116 O(74)–V(72)–O(69) 89.9999 –
117 O(74)–V(72)–N(61) 90.0002 –
118 O(74)–V(72)–O(34) 179.9998 –
119 O(74)–V(72)–N(26) 90 –
120 O(69)–V(72)–N(61) 179.9997 –
121 O(69)–V(72)–O(34) 90 –
122 O(69)–V(72)–N(26) 90.0001 –
123 N(61)–V(72)–O(34) 89.9999 –
124 N(61)–V(72)–N(26) 90.0002 –
125 O(34)–V(72)–N(26) 90.0001 –
126 H(35)–C(33)–C(27) 119.9998 120
127 H(35)–C(33)–N(26) 119.9997 116.5
128 C(27)–C(33)–N(26) 120.0005 123.5
129 H(78)–O(76)–H(77) 119.9995 –
130 H(78)–O(76)–V(71) 120.0004 –
131 H(77)–O(76)–V(71) 120.0001 –
132 V(71)–O(58)–C(56) 109.5001 –
133 V(71)–N(57)–C(59) 120.0003 –
134 V(71)–N(57)–C(42) 119.9998 –
135 C(59)–N(57)–C(42) 114.9999 –
136 V(71)–O(23)–C(21) 109.4998 –
137 H(92)–C(20)–C(21) 120.0002 120
137 H(92)–C(20)–C(19) 120.0001 120
139 C(21)–C(20)–C(19) 119.9996 –
140 H(91)–C(19)–C(20) 124.6011 120
141 H(91)–C(19)–C(18) 124.6013 120
142 C(20)–C(19)–C(18) 110.7976 –
143 H(90)–C(18)–C(19) 124.6019 120
144 H(90)–C(18)–C(17) 124.6013 120
145 C(19)–C(18)–C(17) 110.7968 –
146 O(23)–C(21)–C(20) 115.6987 124.3
147 O(23)–C(21)–C(16) 124.3003 124.3
148 C(20)–C(21)–C(16) 119.9989 120
149 H(89)–C(17)–C(18) 120 120
150 H(89)–C(17)–C(16) 120 120
151 C(18)–C(17)–C(16) 120 –
152 C(24)–C(16)–C(21) 140.0803 120
153 C(24)–C(16)–C(17) 99.9193 120
154 C(21)–C(16)–C(17) 119.9995 120
155 O(76)–V(71)–O(73) 95.1862 –
156 O(76)–V(71)–O(58) 115.7977 –
157 O(76)–V(71)–N(57) 45.3302 –
158 O(76)–V(71)–O(23) 154.1071 –
159 O(76)–V(71)–N(22) 70.4684 –
160 O(73)–V(71)–O(58) 82.7958 –
161 O(73)–V(71)–N(57) 90.0001 –
162 O(73)–V(71)–O(23) 90 –
163 O(73)–V(71)–N(22) 159.2605 –
164 O(58)–V(71)–N(57) 159.2607 –
165 O(58)–V(71)–O(23) 90 –
166 O(58)–V(71)–N(22) 90 –
167 N(57)–V(71)–O(23) 109.4998 –
168 N(57)–V(71)–N(22) 90.0003 –
169 O(23)–V(71)–N(22) 109.5 –
170 H(25)–C(24)–N(22) 124.6646 116.5
171 H(25)–C(24)–C(16) 124.664 120
172 N(22)–C(24)–C(16) 110.6714 123.5
173 V(72)–N(26)–C(33) 119.9996 –
Table 6b2 (continued)
S. No. Atoms Actual bond angles Optimal bond angles S. No. Atoms Actual bond angles Optimal bond angles
64 C(44)–C(39)–C(40) 119.9987 120 174 V(72)–N(26)–C(13) 120.0001 –
65 C(44)–C(39)–S(36) 120 – 175 C(33)–N(26)–C(13) 115.0003 –
66 C(40)–C(39)–S(36) 119.9988 – 176 H(87)–C(14)–C(15) 119.9999 120
67 H(97)–C(40)–C(41) 120.003 120 177 H(87)–C(14)–C(13) 119.9999 120
68 H(97)–C(40)–C(39) 120.0032 120 178 C(15)–C(14)–C(13) 120.0002 –
69 C(41)–C(40)–C(39) 119.9938 – 179 N(26)–C(13)–C(14) 119.9999 120
70 H(99)–C(43)–C(44) 120.0004 120 180 N(26)–C(13)–C(12) 119.9991 120
71 H(99)–C(43)–C(42) 120 120 181 C(14)–C(13)–C(12) 119.9984 120
72 C(44)–C(43)–C(42) 119.9996 – 182 H(86)–C(12)–C(13) 120.0079 120
73 H(98)–C(41)–C(42) 120.0008 120 183 H(86)–C(12)–C(11) 120.008 120
74 H(98)–C(41)–C(40) 120.0005 120 184 C(13)–C(12)–C(11) 119.9841 –
75 C(42)–C(41)–C(40) 119.9987 – 185 H(88)–C(15)–C(14) 120.0001 120
76 C(59)–C(51)–C(56) 106.5371 120 186 H(88)–C(15)–C(10) 120.0001 120
77 C(59)–C(51)–C(52) 133.4032 120 187 C(14)–C(15)–C(10) 119.9998 –
78 C(56)–C(51)–C(52) 120.0557 120 188 H(85)–C(11)–C(12) 120.0081 120
79 H(60)–C(59)–N(57) 145.4489 116.5 189 H(85)–C(11)–C(10) 120.0081 120
80 H(60)–C(59)–C(51) 145.4491 120 190 C(12)–C(11)–C(10) 119.9838
81 N(57)–C(59)–C(51) 69.102 123.5 191 C(15)–C(10)–C(11) 119.9989 120
82 N(57)–C(42)–C(43) 119.9987 120 192 C(15)–C(10)–S(1) 119.9988 –
83 N(57)–C(42)–C(41) 119.9999 120 193 C(11)–C(10)–S(1) 119.9998 –
84 C(43)–C(42)–C(41) 119.9989 120 194 V(71)–N(22)–C(24) 119.9999 –
85 H(80)–O(75)–H(79) 119.9994 – 195 V(71)–N(22)–C(7) 119.9999 –
86 H(80)–O(75)–V(72) 120.0002 – 196 C(24)–N(22)–C(7) 115.0001 –
87 H(79)–O(75)–V(72) 120.0004 – 197 H(83)–C(8)–C(9) 120.0004 120
88 V(72)–O(69)–C(67) 42.58 – 198 H(83)–C(8)–C(7) 120.0001 120
89 V(72)–N(61)–C(68) 120.0001 – 199 C(9)–C(8)–C(7) 119.9995 –
90 V(72)–N(61)–C(48) 119.9996 – 200 N(22)–C(7)–C(8) 119.9996 120
91 C(68)–N(61)–C(48) 115 – 201 N(22)–C(7)–C(6) 119.9986 120
92 V(72)–O(34)–C(32) 97.6087 – 202 C(8)–C(7)–C(6) 119.9993 120
93 H(96)–C(31)–C(32) 119.9995 120 203 H(82)–C(6)–C(7) 120.0079 120
94 H(96)–C(31)–C(30) 120.0004 120 204 H(82)–C(6)–C(5) 120.0081 120
95 C(32)–C(31)–C(30) 120.0001 205 C(7)–C(6)–C(5) 119.984 –
96 H(95)–C(30)–C(31) 138.0414 120 206 H(84)–C(9)–C(8) 119.9997 120
97 H(95)–C(30)–C(29) 138.042 120 207 H(84)–C(9)–C(4) 120.0003 120
98 C(31)–C(30)–C(29) 83.9166 – 208 C(8)–C(9)–C(4) 120 –
99 H(94)–C(29)–C(30) 138.0414 120 209 H(81)–C(5)–C(6) 120.009 120
100 H(94)–C(29)–C(28) 138.0417 120 210 H(81)–C(5)–C(4) 120.0088 120
101 C(30)–C(29)–C(28) 83.9168 – 211 C(6)–C(5)–C(4) 119.9822 –
102 O(34)–C(32)–C(31) 138.4832 124.3 212 C(9)–C(4)–C(5) 120.0003 120
103 O(34)–C(32)–C(27) 101.0414 124.3 213 C(9)–C(4)–S(1) 119.9984 –
104 C(31)–C(32)–C(27) 119.9997 120 214 C(5)–C(4)–S(1) 119.9988 –
105 H(93)–C(28)–C(29) 119.9996 120 215 C(10)–S(1)–C(4) 109.5002 –
106 H(93)–C(28)–C(27) 120.0001 120 216 C(10)–S(1)–O(3) 109.4618 –
107 C(29)–C(28)–C(27) 120.0003 – 217 C(10)–S(1)–O(2) 109.4418 –
108 C(33)–C(27)–C(32) 120 120 218 C(4)–S(1)–O(3) 109.4619 –
109 C(33)–C(27)–C(28) 119.9989 120 219 C(4)–S(1)–O(2) 109.4418 –
110 C(32)–C(27)–C(28) 119.9986 120 220 O(3)–S(1)–O(2) 109.5198 116.6
Figure 12 Structure of bis(maltolato)oxovanadium(IV).
Oxovanadium(IV) complexes of bioinorganic and medicinal relevance: Synthesis, characterization S1097(iii) [Molecular ion]+ (772.94)  *[C4N3H4SO2]+ (157)
**[C4N3H4SO2]+ (157) = 458.94  460.
(iv) [Molecular ion]+ (772.94)  *[C4N3H4SO2]+
(157)  3H+ = 612.94  613.
(v) [Molecular ion]+ (772.94) = 772.94  773.
* = From one diazine moiety; ** = from another diazine
moiety.
From the above fragmentation patterns it appears that the
mass spectral data are consistent with proposed formulation of
the complex in question.
3.5. Electronic spectral studies
The electronic spectra of the complexes were recorded in 103 M
dimethylformamide solutions in the range of 280–800 nm solu-
tions, and the spectral data are given in Table 5. Besides high
intensity charge transfer transitions, compound (1), (3), (4)
and (5) displayed one low intensity d–d transition assignable
to b2 ! 1a1 while compound (2) exhibited two low intensity d–
d transitions at 339 and 426 nm assignable to b2 ! 1a1 and
b2 ! b1, respectively (Maurya et al., 1997). The assignment of
b2 ! 1a1 transition in each case assumes idealized C2vsymmetry. These spectra are typical of oxovanadium(IV) com-
plexes (Maurya and Rajput, 2004; Dutta and Syamal, 1993).
The electronic spectrumof compound, [VO(sal-sdz)2(H2O)]ÆH2O
(1) is shown in Fig. 8.
3.6. Magnetic studies
The observed magnetic moments of the compounds (1)–(4) at
room temperature are in the range 1.68–1.74 B.M., expected
for monomeric oxovanadium(IV) complexes. A low magnetic
moment value of 1.61 B.M. of compound (5) suggests spin
quenching most probably due to ligand bridged dimeric
structure (Maurya et al., 2008b) for this complex. This is
Figure 13 Proposed structure of complexes.
S1098 R.C. Maurya et al.consistent with the zigzag straight line ESR spectrum of this
compound (vide supra).
3.7. Conductance measurements
The observedmolar conductance (14.1–24.3 ohm1 cm2 mol1)
in 103 molar DMF solutions of these complexes are given in
Table 2, and are consistent with the non-electrolytic (Geary,
1971) nature of these complexes. Such a non-zero molar con-
ductance value for each complex in the present study is most
probably due to the strong donor capacity of DMF, which
may lead to the displacement of anionic ligand and change of
electrolyte type.
4. 3D Molecular modeling
Keeping in view the hexa-coordination of all the complexes
(vide infra) and also taking into account the well established
crystal structure (Melchior et al., 1999) of bis(picolinato)oxo-
vanadium(IV) (Fig. 9) (having a monoprotic bidentate (O,
N)-donor) picolinate ligand, similar to monoprotic (O, N)-do-
nor LH ligands in the present investigation, the molecular
modelings of two representative compounds, [VO(sal-
snm)2(H2O)]ÆH2O (3) and [VO(sal-dadps)(H2O)]2Æ2H2O (5)
were carried out with the CS Chem 3D Ultra Molecular Mod-
eling and Analysis Program. These are based on their octahe-
dral structures with axial oxo group and water molecule trans
to O (oxo), and the two molecules of O,N-donor sal-snm/sal-
dadps ligand at the equatorial positions in cis arrangement.
Alternative structures of these compounds having water mole-
cule cis to O (oxo) were not considered suitable due to steric
reason of the ligand sal-snm/sal-dadps. The details of bond
lengths, bond angles as per the 3D structures (Figs. 10 and
11) are given in Tables 6a1,a2, and Tables 6b1,b2, respectively.
For convenience of looking over the different bond lengths
and bond angles, the various atoms in the two compounds in
question are numbered in Arabic numerals. Compound (3)displays a total of 192 measurements of the bond lengths (70
in number), plus the bond angles (122 in number), while com-
pound (5) displays a total of 344 measurements of the bond
lengths (124 in number), plus the bond angles (220 in number).
Except few cases, optimal values of both the bond lengths and
the bond angles are given in Tables 6a1–b2 along with the ac-
tual ones. The actual bond lengths/bond angles given in Tables
6a1–b2 are obtained as a result of energy optimization in
CHEM 3D Ultra (http://www.cambridgesoft.com), while the
optimal bond length/optimal bond angle values are the most
desirable/favorable (standard) bond lengths/bond angles
established by the builder unit of the CHEM 3D. The missing
of some values of standard bond lengths/bond angles may be
due to the limitations of the software, which we had already
noticed in the modeling of other systems (Maurya et al.,
2007, 2008, 2010a, 2015a,b,c). In most of the cases, the actual
bond lengths and bond angles are close to the optimal values,
and thus the proposed structures of compounds (3) and (5)
(and also others) are acceptable (Maurya et al., 2007, 2008,
2010b, 2015a,b,c,d).5. Conclusions
The satisfactory analytical data coupled with the studies pre-
sented above suggest that the complexes prepared in this inves-
tigation are of the general composition [VO(L)2(H2O)]ÆH2O
and [VO(sal-dadps)(H2O)]2Æ2H2O, where, LH = sal-sdzH,
sal-sgnH, sal-snmH or sal-smrH. Keeping in view the mono-
meric hexacoordination and the dimeric hexacoordination of
compound, and the well documented crystal structure (Bur-
guess et al., 1997) of bis(maltolato)-oxovanadium(IV)
(BMOV) (Fig. 12) involving a monomeric bidentate (O, O) do-
nor ligand (similar to (O, N)-donor in the present investiga-
tion), octahedral structures (Fig. 13) with an axial oxo group
have been proposed for complexes (1)–(5). Maurya et al. have
already proposed a similar octahedral structure (Maurya et al.,
2002a,b) (for hexacoordination oxovanadium(IV) complexes).
Oxovanadium(IV) complexes of bioinorganic and medicinal relevance: Synthesis, characterization S1099In complex (5) the Schiff base ligand behaves as a dibasic tet-
radentate ligand which on reaction with VO2+ forms a stable
binuclear oxovanadium(IV) complex. The neighboring vana-
dyl group participates in spin-spin exchange interaction (Mau-
rya et al., 1997) leading to subnormal magnetic moment.
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